As of October 2026, Grantoria lists 141 Cancer Research Grants for Hospital — 84 open right now, across 7 funding agencies. Award amounts range $25K to $50M. The next application deadline is October 22, 2026. All listings are free, with direct links to the official application.
Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Clinical Research Award (CRA) supports clinical research that evaluates disease-specific factors and interventions. Research is intended…
🏛 Defense Health Agency Contracting Activity - DHACA📋 CFDA 12.420⏰ Oct 22, 2026
The National Human Genome Research Institute (NHGRI) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications for research…
🏛 National Institutes of Health📋 CFDA 93.172⏰ Oct 30, 2026
The National Mesothelioma Virtual Bank (NMVB) was established in 2006 to serve as a resource for malignant mesothelioma research. This funding opportunity will advance biomedical research…
🏛 Centers for Disease Control and Prevention - ERA📋 CFDA 93.262⏰ Nov 2, 2026💰
$750,000 – $1,100,000
This notice of funding opportunity (NOFO) invites grant applications for the Research Specialist Award (R50) specifically for clinician scientists supporting NCI-funded clinical trials research. The Research…
🏛 National Institutes of Health📋 CFDA 93.397⏰ Nov 2, 2026
Summary: Supports studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in bone marrow (BMF) failure research…
🏛 Defense Health Agency Contracting Activity - DHACA📋 CFDA 12.420⏰ Nov 4, 2026
The Common Fund Human Virome Program (HVP) aims to extensively and comprehensively characterize the human virome and create tools, models, and methods that will enable an…
🏛 National Institutes of Health📋 CFDA 93.310⏰ Nov 10, 2026💰
$50,000 – $100,000
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for a Clinical Research Network on Antimicrobial Resistance (AMR).…
🏛 National Institutes of Health📋 CFDA 93.855⏰ Nov 10, 2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies for analyzing, targeting, probing, handling, or…
🏛 National Institutes of Health📋 CFDA 93.394⏰ Nov 10, 2026💰
$50,000 – $150,000
Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical…
🏛 Defense Health Agency Contracting Activity - DHACA📋 CFDA 12.420⏰ Nov 16, 2026
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up, and analysis of…
🏛 Defense Health Agency Contracting Activity - DHACA📋 CFDA 12.420⏰ Nov 18, 2026
Summary: The intent of the fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Translational Research Award (TRA) is to support translational research that will accelerate…
🏛 Defense Health Agency Contracting Activity - DHACA📋 CFDA 12.420⏰ Nov 19, 2026
Summary: The fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with…
🏛 Defense Health Agency Contracting Activity - DHACA📋 CFDA 12.420⏰ Nov 19, 2026
This NOFO encourages applications for multi-site exploratory and confirmatory clinical trials focused on promising interventions; biomarker or outcome measure validation studies that are immediately preparatory to…
🏛 National Institutes of Health📋 CFDA 93.853⏰ Nov 19, 2026
The NIH Common Fund, National Institute on Aging, National Cancer Institute and additional NIH Institutes and Centers (ICs) intend to publish a Notice of Funding Opportunity…
🏛 National Institutes of Health📋 CFDA 93.310⏰ Nov 23, 2026
CDC/ATSDR is inviting research proposals to study risk factors for Amyotrophic Lateral Sclerosis (ALS). Studies on military service, contact sports, traumatic brain injury, neuroinflammation, and infections…
🏛 Centers for Disease Control and Prevention - ERA📋 CFDA 93.061⏰ Dec 1, 2026💰
up to $500,000
How many cancer research grants for hospital are available?
Grantoria currently lists 141 cancer research grants for hospital, of which 84 are open for applications right now. The database is refreshed daily from official federal sources (Grants.gov and SAM.gov).
When is the next deadline?
The next application deadline is October 22, 2026 — about 1 days away. Deadlines vary by program; open any grant to see its exact closing date and application window.
How much funding is available?
Award sizes range from $25K to $50M, depending on the program and applicant. Each grant shows its specific funding range where the agency has published one.
Is Grantoria free to use?
Yes — Grantoria is completely free. No account or subscription is required to browse cancer research grants for hospital, view deadlines and eligibility, or reach the official application.
How do I apply?
Open any grant to see its full profile — eligibility, required documents, deadlines and a direct link to the official application on the funding agency's website. You apply through the federal portal; Grantoria simply helps you find the right opportunity.
About Cancer Research Grants for Hospital
Cancer research grants for hospitals fund clinical trials, translational oncology studies, and tumor biology research that advances treatment innovation and patient outcomes. 7,389 active grants support this work, with the National Institutes of Health leading as the primary funding agency, alongside the Department of the Army and FDA backing specialized research initiatives.
Award amounts typically range from $500K to $700K, with all grants using a competitive application process—meaning hospitals compete directly on research merit and institutional capacity. Notably, zero cost-sharing requirements remove matching fund barriers. To refine your search, filter by research focus area to target grants aligned with your specific cancer type or treatment methodology.
